Stephen J Freedland

109PUBLICATIONS
153CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Context learningEpidemiological methodsFamily and household studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (109)

|Aug 10, 2026
How low do you need to go? Association between various prostate-specific antigen response measures and clinical outcomes in metastatic castration-sensitive prostate cancer in the Veterans Health Administration data.

|Jul 09, 2026
Enzalutamide in biochemically recurrent prostate cancer: clinical implications from EMBARK for real-world practice.

|Jul 08, 2026
Integrating Natural Language Processing With ChatGPT to Improve Quality of Artificial Intelligence Summaries of Prostate Cancer Consultations.

|Jun 24, 2026
Criteria Clinicians Use to Classify Patients as High Risk in Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer.

|Jun 23, 2026
Enzalutamide in biochemically recurrent prostate cancer: key findings from subsequent analyses of EMBARK and their implications in clinical practice.

|Jun 01, 2026
Real-World Treatment Patterns for Patients with High-Risk Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer.

Pageof 19

Frequent Collaborators

11 joint publications

Nadine Friedrich

11 joint publications

Amanda M De Hoedt

9 joint publications

Matthew R Cooperberg

9 joint publications

Zachary Klaassen